The research and construction of drug regulatory science has become the focus of drug supervision strategies in the world in this century, and the construction of talent teams is one of the first considerations in the research and construction of regulatory science. China is still in its infancy in the cultivation of regulatory science talents, and there are prominent problems such as the small scale, shallow degree, and chaotic system of talent cultivation. The United States has been exploring the cultivation of talents for drug regulatory science for many years, and has formed a mature regulatory science talent training system. This article studies the innovative practice of the training of regulatory science talents in the United States, analyzes and summarizes its talent training orientation and specific training measures to understand the deficiencies in China, and on the basis of which, suggestions were put forward to improve the cultivation system of drug regulatory science talents in China.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |